These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
50 related items for PubMed ID: 4859726
1. Nonsuppressible insulin-like activity of human serum. Jakob A, Bürgi H, Froesch ER, Labhart A. Ger Med Mon; 1967 Jun; 12(6):286-92. PubMed ID: 4859726 [No Abstract] [Full Text] [Related]
2. Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA. Jakob A, Hauri C, Froesch ER. J Clin Invest; 1968 Dec; 47(12):2678-88. PubMed ID: 5725280 [Abstract] [Full Text] [Related]
4. Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation. Kahn CR, Megyesi K, Roth J. J Clin Invest; 1976 Feb; 57(2):526-9. PubMed ID: 1254732 [Abstract] [Full Text] [Related]
5. Quantitation and partial characterization of nonsuppressible insulin-like activity in serum and tissue extracts of the rat. Solomon SS, Poffenbarger PL, Hepp DK, Fenster LF, Ensinck JW, Williams RH. Endocrinology; 1967 Aug; 81(2):213-25. PubMed ID: 4952847 [No Abstract] [Full Text] [Related]
6. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. Zapf J, Schoenle E, Jagars G, Sand I, Grunwald J, Froesch ER. J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829 [Abstract] [Full Text] [Related]
7. Nonsuppressible insulin-like activity: biological activity and receptor binding. Zapf J, Mäder M, Waldvogel M, Froesch ER. Isr J Med Sci; 1975 Jul; 11(7):664-78. PubMed ID: 169212 [No Abstract] [Full Text] [Related]
8. The insulin inhibitory capacity of plasma versus serum. Benson B, Miller CW. Horm Metab Res; 1970 Jan; 2(1):45-6. PubMed ID: 5520752 [No Abstract] [Full Text] [Related]
9. From insulin and insulin-like activity to the insulin superfamily of growth-promoting peptides: a 20th-century odyssey. Blumenthal S. Perspect Biol Med; 2010 Jan; 53(4):491-508. PubMed ID: 21037404 [Abstract] [Full Text] [Related]
10. [Conformational changes in blood serum proteins in the process of effecting their transport function]. Sorkina DA. Vopr Med Khim; 1967 Jan; 13(3):263-70. PubMed ID: 5597200 [No Abstract] [Full Text] [Related]
12. [Content of some metabolites and activity of a series of enzymes following abrupt cessation of insulin action]. Genes SG, Itskova RF, Kozopolianskaia MM, Poltorak VV. Vopr Med Khim; 1971 Jun; 17(5):529-34. PubMed ID: 4330809 [No Abstract] [Full Text] [Related]
13. The purification and partial characterization of an insulin-like protein from human serum. Poffenbarger PL. J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080 [Abstract] [Full Text] [Related]
16. The presence of a serum insulin--binding activity in atherosclerotic vascular disease. Fratino P, Jucci A, Criffò A, Bellazzi R. Boll Soc Ital Biol Sper; 1978 Jan 30; 54(2):184-91. PubMed ID: 737065 [No Abstract] [Full Text] [Related]
17. [Effect of serum fractions on the incorporation of tritiated thymidine in activated lymphocytes: I. Human serum from normal adult subjects]. Schimpff RM, Repellin AM, Chatelain P, Bozzola M, Guidoux S. C R Acad Sci III; 1986 Jan 30; 302(18):651-3. PubMed ID: 3091201 [Abstract] [Full Text] [Related]